US: Reed's confident over FDA inquiry
Reed's Natural Energy Elixir drink bore nutrient content claims that were not authorised by regulation
Reed's has said that a US Food & Drug Administration (FDA) ruling that the company has misbranded some of its products will not have a material impact on its business.
A letter from the FDA to Reed's' CEO, Christopher Reed, stated that the company's Natural Energy Elixir drink bore unauthorised nutrient content claims.
One such statement was the claim that the energy drink is "rich in epigallacetechin gallate (EGCG) a powerful antioxidant". Another stated: "Camu Camu- a . . . fruit with the highest concentration of vitamin C of any plant".
The letter from the agency's California office noted: "The violations cited in this letter are not intended to be an all-inclusive statement of violations that exist at your facility, and in connection with your products." However, it added: "It is your responsibility to ensure that your firm and all of your products comply with the Act and FDA regulations.
"You should take prompt action to correct the violations described in this letter. Failure to do so may result in regulatory action without further notice. Such action may include, but is not limited to, seizure or injunction," the letter stated.
However, in a statement today (25 August), Reed's said that the company is "proactively and openly addressing" the FDA's labelling concerns, and has taken measures "to immediately correct" labelling.
"The FDA seems to be increasing pressure to improve labelling and ingredient descriptions," said Reed's COO, Terry Foucaut. "We applaud the push toward increased disclosure. We have enthusiastically corrected these minor points in our packaging, and we look forward to closing this matter with the FDA as soon as they are able to review our responses."
Reed's said it is awaiting a response from the FDA on the proposed corrective measures.
- Job cuts not the whole story at AB InBev - Comment
- Diageo's smart Seedlip sustainability move
- Pernod Ricard Q4/FY 2016 results - Preview
- Why Vietnam is the next beer battleground
- Brown-Forman Q1 2017 results - Preview
- CEO Paul Schaafsma set to leave Accolade Wines
- AB InBev to cull 5,500 jobs after SABMiller buy
- Diageo revamps Gordon's gin bottle in UK
- Heineken unveils new mid-strength lager Heineken 3
- ASA bans Diageo's Captain Morgan UK ad
- The Next Seven Big Beverage Markets
- Global rum insights - market forecasts, product innovation and consumer trends
- Adultifying Soft Drinks; Capitalizing on rising adult demand for non-alcoholic beverages
- Global RTD insights - market forecasts, product innovation and consumer trends
- Carlsberg AS (CARL B) - Financial and Strategic SWOT Analysis Review